AIS

18 clinical trials · Condition

Record	Firm	Date
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020)	Shanghai Bovax Biotechnology Co., Ltd.	2021-05-28
A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke (NCT05496361)	Suzhou Zenith Vascular Scitech Co., Ltd.	2021-01-24
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016)	Shanghai Bovax Biotechnology Co., Ltd.	2020-09-19
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291)	Shanghai Bovax Biotechnology Co., Ltd.	2020-05-28
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366)	Shanghai Bovax Biotechnology Co., Ltd.	2020-04-28
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101)	Shanghai Bovax Biotechnology Co., Ltd.	2018-10-10
NBP in Adult Patients With Acute Ischemic Stroke (AIS) (NCT02905565)	CSPC-NBP Pharmaceutical Co., Ltd.	2018-02-28
Evaluation of the AIIS Using Hip Ultrasound(AIISUS) (NCT03105063)	Tel-Aviv Sourasky Medical Center	2017-04-01

Every clearance here is in the API, with alerts when new ones post.